pd-l1 expression in metastatic urothelial cancer
Published 4 years ago • 97 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
7:55
pd-l1 expression in bladder cancer
-
2:12
impact of pd-l1 expression on urothelial carcinoma genomic alteration profile
-
1:53
dr daniel petrylak explains pd-1, pd-l1 expression in bladder cancer treatment
-
3:36
anti-pd-l1 immunotherapy with mpdl3280a in metastatic bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
2:26
pd-l1 immunotherapy in bladder cancer
-
1:32
utility of pd-l1 as a biomarker in bladder cancer
-
7:06
pd-l1 in metastatic bladder cancer - bladder cancer video library
-
1:30
hhla2 vs pd-l1 expression in urothelial tumors
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:30
dr. bellmunt on pd-l1 data in bladder cancer
-
1:25
pd-1 and pd-l1 expression in esophageal and gastric cancer
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
3:39
role of pd-l1 testing in urothelial carcinoma
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
1:58
dr. sonpavde on combining vegf/pd-1 inhibitors in metastatic urothelial carcinoma
-
0:39
predicting immunotherapy response in bladder cancer